chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Following the booster, we found out that we were pregnant, and we had a doctor's visit shortly after. The first appointment was March 17, 2022, and that was confirmation of the pregnancy. On March 21, 2022, we had an ultrasound, and they were unable to find the fetus. I went for additional blood work and had a follow up ultrasound on March 28, 2022. At that point it was a miscarriage. On April 18, 2022, went back to the doctor and made sure that everything was going okay. Having a normal period and emotional concerns were addressed for the recent appointment.
Headache Shortness of breath Smart watch indicated Atrial Fibrillation (112 BPM average) on 4/12 at 3:04pm
deep muscle pain cont, some itching rash (torso, extremities); red bumps on torso (from 2 hr p/inj to current date);
Chronic upper left arm, left shoulder and blade, and left arm down to wrist ?.the injection site area pain is the most profound. Over 2 months now. Left arm has limited range of motion and limited use without further aggravation of the pain. Sleep is restricted to laying on my back with my left arm at my side
This spontaneous report as received from a physician, initially via a company representative, refers to a 13 year old patient of unknown gender. No medical history provided. On 10-FEB-2004 the patient was vaccinated with VARIVAX (dose 1). No concomitant medications were provided. On 22-JAN-2014 the patient was supposed to receive a 2nd dose of VARIVAX, but received ZOSTAVAX by accident. No adverse events were reported. Additional information has been requested.
Irregular menstrual cycle (experiencing a heavier flow, as well as, bleeding more often than I'm not), unable to regulate body temperature (always hot/sweating even when sitting in air conditioned rooms with fans)
Initial Stuffy nose, headache for 2 days. Mild fever started on 10/26 and spiked to 102.5 by the evening of 10/28. Fever was gone on 10/29 at 3pm. Vomiting occured at 10pm on 10/28 and lasted approximately 8 hours straight. Flu test was negative. Headache is still present 3 weeks later.
The patient reported getting his second COVID vaccine on July 2nd. He reported that 3 weeks later which would be July 21st he started having pain in his left leg. He noted severe fatigue that would not go away. A few days later he started having pain in his chest. He was previously hiking 5 miles several times a week. He reached out to his PCP about the chest pain and they ordered an x-ray. His pain continued. He went out for one of his 5 mile hikes, but made it less than 1 mile and had to rest 13 times just to get back home. He presents to the ER on August 11th and was found to have a large DVT from left groin to ankle and large bilateral pulmonary emboli. He required hospitalization.
Patient had no known adverse events, he was given an adult dose 1ML and is 13 years old. He should have been given the 0.5ML dose.
fever of 100.9 F; headache; bodyaches; nausea; hardness at injection site; swelling at injection site; approximately a 3 inch circular rash is present at injection site.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE RASH (approximately a 3 inch circular rash is present at injection site.), PYREXIA (fever of 100.9 F) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included QUETIAPINE FUMARATE (SEROQUEL) and CALCIUM for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE RASH (approximately a 3 inch circular rash is present at injection site.). On 11-Apr-2021, the patient experienced PYREXIA (fever of 100.9 F), HEADACHE (headache), MYALGIA (bodyaches) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 12-Apr-2021, PYREXIA (fever of 100.9 F), HEADACHE (headache), MYALGIA (bodyaches) and NAUSEA (nausea) had resolved. At the time of the report, VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE RASH (approximately a 3 inch circular rash is present at injection site.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, Body temperature: 100.9 f (High) fever of 100.9 F.
Patient returned to office approx. 30 min after receiving vaccines. Pt. had vomited, pale color and blue lips. BP taken 98/60 POX 98%, clear lungs, heart RRR 72. Pt. given apple juice, blow by O2. Felt better and released home stable.
2 days later began having rash on trunk and spreading to neck/face, began taking antihistamines, following day (3 days later) had rapid heartbeat and trouble breathing and treated at hospital for possible/probable anaphylaxis per treating physician.   Also followed up with allergy center, continued taking steroids and antihistamines for 1 week to keep reaction under control.   Was cleared by allergy office to get dose #2 and has similar rash appear around 20-24 hours after receiving dose 2, spreading to neck and face within a few hours despite antihistamine use, needing to be treated with course of steroids again.
4/30 received vaccine in office - pt tolerated well. Mom called office 5/3 reddened area only - ? ethyl chloride used but to office for eval. determined normal local reaction. Mom already hesitant about vaccines - reassured. 5/9 pt to office for acute URI - no mention of vaccine reaction by mom. 5/25 Mom still concerned about local reaction - into office for MD eval. Mom reassured no sign of dangerous reaction w/ lump at site.
Patient was sat out in lobby after vaccine, around 11:05am patients spouse grabbed provider  patient was complaining of chest tightness, throat closing sensation, "weird" feeling over body.
CHILLS NOT CONTINUOUS "EVERY 10 MINUTES"; FEVER; SLIGHT ARM PAIN NOT BAD; This spontaneous report received from a patient concerned a 23 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcoholic user, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies. the patient did not have any history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced slight arm pain not bad. On 17-MAR-2021, the subject experienced chills not continuous "every 10 minutes". On 17-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.12 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from slight arm pain not bad, and had not recovered from fever, and chills not continuous "every 10 minutes". This report was non-serious.
Fatigue staring at 3pm. Muscle aches, chills, and headache starting at 6pm and lasting all through the next day. Persistent muscle aches on the day after
Depigmentation 1cm x 1/2cm at site of injection, right thigh.
No addittional adverse effects reported; MMR II that underwent temperature excursions was administered; This spontaneous report was received from reporter stated as other and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications, past drug reactions or allergies were not reported.  On 11-OCT-2021, the patient was vaccinated with an improperly store measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live rHA (recombinant human albumin) (M-M-R II) (strength, dose, vaccination scheme frequency, route of administration and anatomical site of application were not provided; lot number T033814 had been verified to be a valid number with an expiration date reported and established as 05-OCT-2022) for prophylaxis (product storage error).   The vaccine underwent a temperature excursion that was reported as following: above 9 degrees Celsius (C) (12.4C) for a time frame of 0 hours, 53 minutes and 0 seconds; above 9 degrees C (9.6C) for a time frame of 0 hours, 34 minutes and 0 seconds; above 9 degrees C (9.5C) for a time frame of 0 hours, 23 minutes and 0 seconds; and above 9 degrees C (8.5C) for a time frame of 0 hours, 9 minutes and 0 seconds. It was reported that the suspect vaccine did not had a previous temperature excursion. No additional adverse effect was reported (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2112USA006870:
Within minutes after the vaccine I noticed my arm swollen and my fingers started swelling as well. It was moderate swelling though. the injection site swollen up and it was hard for me to breathe as well. Not sure if it was the shot itself or if I was just nervous, anxious about receiving the shot. I received the 1st dose on 01/13/21 and I was supposed to receive the second one on 02/10/21 and because I had a flare up on my face, my face swollen up around 01/21 - 01/24, and I found out that I had the infection on my gums and had to get the teeth extracted. It seems that after receiving the vaccine my overall health that is not at the best just got worse. I could not stand for a long period of time, it aggravated things that were already going on with my system.  It affected my uterus, I already have bleeding issues but now I have very heavy periods since the vaccine. And they are lasting longer. I also had a lot of pain at the injection site and also a severe headache.  I also am now battling 2 different kinds of yeast infection that are resistant to the meds given to me.
Left arm soreness, difficulty lifting over head, swelling of lymph nodes, swelling of tissue under arm to rib cage and muscle aches.
It was reported that a 2-year-old male received a dose of Tripedia(lot#U0582AA) vaccine on 7/24/02. Patient developed a large local swelling and induration at injection site measuring 8x8cm. There were two other patients who experienced the same reaction with this lot number.
shortness of breath; nausea; swelling and redness all over her arm; redness all over her arm; high fever; Initial information received on 01-Dec-2022 regarding an unsolicited valid non-serious case received from patient.  This case involves a 71 years old female patient who experienced shortness of breath, nausea, swelling and redness all over her arm, redness all over her arm and high fever after receiving vaccine diphtheria, tetanus and acellular pertussis vaccine.  The patient's past medical history included mole biopsied (Biopsy) and allergic to red dye. The patient's past medical treatment included Patient found out she was allergic to red dye when she started taking prenatal medications and also stated that she has to take a Benadryl each time she takes an antibiotic due to her lactose allergy. The patient's past vaccination(s) included pnuemonia-23 shot with horrible headache and cellulitis on her arm. The patient's past family history was not provided. At the time of the event, the patient had ongoing allergies and believes both her and her daughter may have HaT syndrome (Hypersensitivity) and lactose allergy (Lactose intolerance).  On an unknown date, the patient received a dose of suspect diphtheria, tetanus and acellular pertussis vaccine produced by unknown manufacturer (form, strength, dose, frequency, lot number, expiry date: unknown) via unknown route in unknown administration site for Prophylactic vaccination.  On an unknown date the patient had shortness of breath (dyspnoea), nausea, swelling and redness all over her arm (peripheral swelling), redness all over her arm (erythema) and high fever (pyrexia) (unknown latency) following the administration of diphtheria and tetanus and acellular pertussis vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events (shortness of breath, nausea, swelling and redness all over her arm, redness all over her arm, high fever).  At time of reporting, the outcome was Unknown for the events.
Pt felt nausea after first dose. Vitals were taken and were within normal limits. He was given water and his legs were elevated. Told to do deep breathing. Patient felt better and left with no more concerns
tremors; muscle weakness's; High Blood Pressure; Atopic Migraines; non Epileptic seizures; abnormal gait; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  A 31-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Apr2021 11:45 (Lot number: EN206) at the age of 31 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). Patient did not have COVID prior vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. Past drug history included: Advair, reaction: "Known allergies: Advair"; Codeine, reaction: "Known allergies: Codeine". Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6205, Location of injection: Arm Left, Vaccine Administration Time: 11:15 AM), administration date: 31Mar2021, when the patient was 31 years old, for COVID-19 Immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: TREMOR (disability) with onset 21Jun2021 06:30, outcome "recovering", described as "tremors"; MUSCULAR WEAKNESS (disability) with onset 21Jun2021 06:30, outcome "recovering", described as "muscle weakness's"; HYPERTENSION (disability) with onset 21Jun2021 06:30, outcome "recovering", described as "High Blood Pressure"; MIGRAINE (disability) with onset 21Jun2021 06:30, outcome "recovering", described as "Atopic Migraines"; SEIZURE (disability) with onset 21Jun2021 06:30, outcome "recovering", described as "non Epileptic seizures"; GAIT DISTURBANCE (disability) with onset 21Jun2021 06:30, outcome "recovering", described as "abnormal gait" (also reported as abnormal gate). Therapeutic measures were not taken as a result of tremor, muscular weakness, hypertension, migraine, seizure, gait disturbance. Patient did not have COVID tested post vaccination. Since the vaccination, the patient had been tested for COVID-19.
Lump. Redness and swelling to left thigh area. Warm to touch. 1) cool packs 2) Benedryl 3) Augmentin for Cellulitis.
pt recvd vax; pt had red area site of inject; mom said area on RT. ant lat.  thigh inc in size; no tenderness but warm to touch; imp: sterile abscess;
Shortness of breath, followed by ER visit, had pulm f/u which reports "I suspect elevated right hemidiaphragm is due to zoster vaccine; the temporal association is very tight and there are no other obvious causes of phrenic nerve injury in this patient." - staff physician pulmonary medicine.
Patient presents with acute encephalopathy. Patient was hypothermic, hypotensive with SBP 79, and encephalopathic. Patient had apneic episodes and was subsequently intubated for airway protection in setting of encephalopathy. Lab work notable for hemoglobin 6.6, TSH of 15, and initial troponin of 164. Patient had CXR without focal consolidation, repeat CXR showing ETT in appropriate position. Patient had CTH and CTA H/N with 50% stenosis of right proximal ICA at bifurcation and chronic versus acute sinusitis. ER consulted Neurology for evaluation of encephalopathy. In ER patient received acyclovir, vancomycin, ceftriaxone, and ampicillin as well as 2L IVFs. MICU was consulted given respiratory failure 2/2 encephalopathy for admission.      For his altered mental status workup infectious workup which was negative including peritoneal fluid with a total cell count 5 stain without organisms, blood cultures were negative, UA did not suggest UTI, and negative chest x-ray.  CT head did show acute sinusitis for which she received a course of Rocephin.  Eeg not show seizure, TSH 15 but normal T4, normal cortisol.  Patient did develop shock and required pressors but this was suspected to be sedation related.  Patient was extubated on February 26th to eventually room air.       Discharge Disposition/Condition Disposition: Home Condition: Stable (s/sx potential problems absent or manageable)
This spontaneous report as received from a pharmacist refers to a 56 years old female patient with no pertinent medical history and no drug reactions or allergies. The reporter stated that she held a ZOSTAVAX clinic, on 02-MAY-2014, patient was administered with ZOSTAVAX lot number K000456, expiration date 15-DEC-2014, dose single dose, route SQ for vaccination. On an unknown date in May 2014, patient the patient developed redness, swelling and induration at injection site. The pharmacist stated she became aware of the adverse events the patient was experiencing on the weekend (03-MAY-2014 and 04-MAY-2014). The vaccine clinic took place at a high school. Vaccine recipient was teacher. The pharmacist spoke to the school nurse on Monday 05-MAY-2014. The school nurse shared with the pharmacist that the adverse experiences, the teach was experiencing, was resolving. There was no hospitalization. No specific treatments mentioned. The pharmacist shared the initials, gender and age of each ZOSTAVAX vaccine recipient. All vaccine recipients were women. The pharmacist learned from school nurse that one of the patient experiences of redness spread to over 5 inches from injection site, the pharmacist unable to identify which patient. Patient sought medical attention (called pharmacy). The patient did not receive treatment for the adverse event. There was no Lab diagnosis or studies performed. The outcome of redness, swelling and induration at injection site was recovering. No product quality complaint was involved. This is one of 9 reports from the same source. Additional information has been requested.
Bruising and pain along rib cage; Bruising and pain along rib cage; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CONTUSION (non-serious), MUSCULOSKELETAL CHEST PAIN (non-serious), outcome "unknown" and all described as "Bruising and pain along rib cage". Clinical course: the patient experienced bruising and pain along rib cage on same side of body as the arm where vaccine was received.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Hoarseness; 4 days red eye; 3 days cough; 7 days fatigue; 6 days
I had the vaccine and the first one was fine but the second one that I had felt like a nerve was hit on the sight of getting the vaccine. I had pain in my left shoulder for 3 days, it slowly subsided but then came back last week and I cannot raise my arm in any direction, it's throbbing and I cannot use it to drive and it hurts to type etc the pain has only gotten worse as the days go on and I can't lift it at all.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concomitant products included RISPERIDONE, VITAMIN C [ASCORBIC ACID] and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced MYALGIA (sore arm). On 24-Mar-2021, MYALGIA (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication includes Man's 50+ gummy.  The Treatment information was not provided.
I was in menopause for over a year. I just now am getting my period again.  The first period was end of Dec 2021 and coincided with me also having Covid & now I have it again in January. I have no other  on/gym or other health issues.
cold; pain; chills; headache; This spontaneous case was reported by a patient and describes the occurrence of NASOPHARYNGITIS (cold), PAIN (pain), CHILLS (chills) and HEADACHE (headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A and 032M20A) for COVID-19 vaccination.     Patient didn't have allergies but was very sensitive in general.  The patient's past medical history included Mitral valve replacement and Pacemaker insertion (cardiac). Concurrent medical conditions included Heart disease, unspecified since 2008. Concomitant products included APIXABAN (ELIQUIS) for Prophylaxis, FUROSEMIDE for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold), PAIN (pain), CHILLS (chills) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (cold), PAIN (pain), CHILLS (chills) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.         It was reported that patient was always had adverse reactions, but not as longer as this time.  The patient was recovered form events a couple of days after first 3 doses.   This case was linked to MOD-2022-563534 (Patient Link).
Excessive soreness over a period of months. I did not seek treatment until increasing and significant loss of mobility at about 1 year later.  At that time I was diagnosed with adhesive capsulitis.  Treatment consisted of cortisone injection and physical therapy.  Pain still present in shoulder.
Pt woke this morning with itching and redness reaction. The itching was reported all over her body, redness at injection site. Pt stated she had a red rash on face earlier in the day but that has gone away. She said she felt run down and tired all day. She saw PA at her primary care physician's office today, was given a steroid cream from provider, told to apply cream and watch for any other reaction and let PA know.
Pt recvd Hep B vax on 20JUN91 & recvd 2nd dose 18JUL91 & exp generalized muscle & joint pain; No further details were provided;